This 1 Innovation Could Disrupt Pfizer and Moderna's Vaccine Supremacy
5/3 16:37
It's not news that Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are the undisputed winners of the race to develop and commercialize a coronavirus vaccine. Pfizer expects to make around $32 billion this year from sales of Comirnaty, whereas Moderna expects roughly $19 billion fro...